Veradermics, Incorporated experienced a single notable transaction within the last ninety days. An affiliate entity, the John W. Childs 2013 Revocable Trust, filed a proposed sale of 100,000 shares valued at approximately 10.9 million dollars. This activity occurs amidst a 12.3 percent stock price increase over the same period, with no recent earnings report data available.